Genenta (NASDAQ: GNTA) cancels vote on Saentra Forge rebrand

Rhea-AI Filing Summary

Genenta Science S.p.A. has cancelled its previously scheduled Extraordinary Shareholders’ Meeting of March 25–26, 2026, which was convened to approve a change of the company’s name to Saentra Forge S.p.A. and a related Nasdaq ticker change.

The board decided to revoke the meeting call after concluding that the Genenta name still carries strong recognition, value, and market presence built over more than a decade. The company notes that the already approved extension of its corporate purpose, linked to Italy’s Golden Power legislation, remains in an early development phase, and the Saentra Forge branding requires further positioning before any future rebrand.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2026

Commission File Number: 001-41115

GENENTA SCIENCE S.P.A.

(Translation of registrant’s name into English)

Via dell’Annunciata 31

20121 Milan, Italy

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Other Events

Proposed Change to Corporate Name and Nasdaq Ticker Symbol

As previously disclosed in the Current Report on Form 6-K of Genenta Science S.p.A. (the “Company”) filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 3, 2025, at the Company’s Ordinary and Extraordinary Shareholders’ Meeting held on October 29, 2025, the Company’s shareholders approved the proposed amendment to Article 4 of the Company’s by-laws to extend the Company’s corporate purpose to include all sectors covered by the Italian Law Decree 21/2012 (i.e. Golden Power legislation). In connection with the extension of the Company’s corporate purpose, the Company intended to adopt the new corporate name of “Saentra Forge S.p.A.” and a new Nasdaq ticker symbol of “SAEN.” As previously disclosed in the Current Report on Form 6-K of the Company filed with the SEC on January 27, 2026, the Company had scheduled an Extraordinary Shareholders’ Meeting (the “Meeting”) to be held on March 25, 2026, at 5:00 p.m., on first call, and, if necessary, on March 26, 2026, at 5:00 p.m., on second call, for the purpose of obtaining shareholder approval of the corporate name change. On March 23, 2026, the Company issued a notice of revocation, announcing that the Board of Directors of the Company has resolved to revoke the call of the Meeting and the Meeting is hereby cancelled. Following further analysis, it emerged that, at present, the name “Genenta” retains significant recognition, value and market presence, having been associated with the Company’s history and identity for over a decade. Moreover, the approved extension of the Company’s corporate purpose, to which the proposal for adopting a new corporate name was linked, is still in the initial phase of development. The Notice is posted on the Company’s website at www.genenta.com under the Investors tab.

SUBMITTED HEREWITH

Attached to this Report for the month of March 2026, and incorporated by reference herein, is:

Exhibit No.		Description
99.1		Notice of Revocation of the Extraordinary Shareholders’ Meeting of 25-26 March 2026.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	GENENTA SCIENCE S.P.A.
	By:	/s/ Pierluigi Paracchi
	Name:	Pierluigi Paracchi
	Title:	Chief Executive Officer

Dated: March 23, 2026

Exhibit 99.1

Genenta Science S.p.A.

Registered office: Milan, via Dell’Annunciata 31

Subscribed and paid-up share capital of Euro 893,218.30

Tax code and registration number with the Milan Monza-Brianza Lodi Companies’ Register: 08738490963

NOTICE OF REVOCATION

OF THE EXTRAORDINARY SHAREHOLDERS’ MEETING OF 25-26 MARCH 2026

It is hereby announced that the Board of Directors of Genenta Science S.p.A. (the “Company”) has resolved to revoke the call of the Extraordinary Shareholders’ Meeting previously scheduled for March 25, 2026, on first call, and March 26, 2026, on second call, which had on its agenda the proposed amendment to Article 1 of the by-laws to change the Company’s name from Genenta Science S.p.A. to Saentra Forge S.p.A.

Following further analysis, it has emerged that, at present, the name “Genenta” retains significant recognition, value, and market presence, having been associated with the Company’s history and identity for over a decade. Moreover, the approved extension of the Company’s corporate purpose, to which the proposal for adopting a new corporate name was linked, is still in the initial phase of development, and the proposed new name requires further development, positioning, and market recognition before replacing “Genenta,” while the Company continues to regard the adoption of the new name as a strategic objective.

Milan, 23 March 2026

For the Board of Directors

The Chairman Pierluigi Paracchi

FAQ

What did Genenta Science (GNTA) announce in this March 2026 report?

Genenta Science announced it revoked an Extraordinary Shareholders’ Meeting that had been called to vote on changing the company’s name to Saentra Forge S.p.A. The board cancelled the meeting after reassessing brand strength and the early stage of its expanded corporate purpose.

Why did Genenta Science (GNTA) cancel the vote on changing its corporate name?

The board concluded the Genenta brand still holds significant recognition and value built over more than a decade. It also highlighted that the expanded corporate purpose is still in an initial development phase and the proposed Saentra Forge name needs further positioning and market recognition.

Was Genenta’s corporate purpose extension still going ahead despite the cancelled meeting?

Yes, the extension of Genenta’s corporate purpose remains in place, having been previously approved by shareholders in October 2025. The cancelled meeting concerned only the proposed change of the corporate name, which had been linked conceptually to that broader corporate purpose expansion.

What name and ticker will Genenta Science (GNTA) continue to use after this decision?

Genenta will continue operating under the name Genenta Science S.p.A. and maintain its existing Nasdaq ticker rather than adopting the proposed Saentra Forge S.p.A. and “SAEN” ticker. The company still views a future name change as a strategic objective but delayed the immediate step.

Where can investors find the official notice about Genenta’s cancelled meeting?

The notice of revocation is available on Genenta’s investor website at www.genenta.com under the Investors tab. It is also included as Exhibit 99.1 to this March 2026 report, formally documenting the board’s resolution to revoke the Extraordinary Shareholders’ Meeting.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 7.5 KB